Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Department of Chemistry and Biochemistry, University of Mississippi, University, MS 38677, USA.
Trends Mol Med. 2020 Dec;26(12):1064-1067. doi: 10.1016/j.molmed.2020.08.005. Epub 2020 Sep 11.
As the major feature of pancreatic ductal adenocarcinoma (PDAC), desmoplastic stroma poses a significant obstacle for treatment. Recent studies revealed that connective tissue growth factor (CTGF) aggravates the fibrotic environment and drives cancer initiation and progression, thus suggesting CTGF as a novel target for PDAC treatment.
作为胰腺导管腺癌 (PDAC) 的主要特征,纤维性基质构成了治疗的重大障碍。最近的研究表明,结缔组织生长因子 (CTGF) 加剧了纤维化环境,并驱动癌症的发生和进展,因此 CTGF 被认为是 PDAC 治疗的一个新靶点。